Skip to main content
All lobbying filings

VENN STRATEGIES

Lobbying for PACIRA PHARMACEUTICALS INC. · Pharmaceutical company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Jan 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Improving access to non-opioid approaches to pain management.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem